Home/Pipeline/Glean Urodynamics System

Glean Urodynamics System

Diagnosis of lower urinary tract symptoms (e.g., incontinence, overactive bladder, voiding dysfunction)

ApprovedActive

Key Facts

Indication
Diagnosis of lower urinary tract symptoms (e.g., incontinence, overactive bladder, voiding dysfunction)
Phase
Approved
Status
Active
Company

About Bright Uro

Bright Uro, founded in 2019 and based in San Francisco, is a commercial-stage medical device company in the urology sector. Its flagship product, the Glean UDS, is an FDA-cleared, non-invasive, wireless monitoring system that represents a significant departure from traditional, catheter-based urodynamic testing. The company targets a large market of approximately 80 million US adults with lower urinary tract symptoms, aiming to expand patient access, improve diagnostic reliability, and enhance the overall patient and clinician experience. Bright Uro is positioned as a private, revenue-generating company with a clear focus on commercializing its innovative device.

View full company profile

Therapeutic Areas